Affinity-Driven Selection of Tripeptide Inhibitors of Ribonucleotide Reductase

Affinity-Driven Selection of Tripeptide Inhibitors of Ribonucleotide Reductase Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators Peptidomimetic Inhibitors of Herpes Simplex Virus Ribonucleotide Reductase with Improved in Vivo Antiviral Activity Leupeptazin, a highly modified tripeptide isolated from cultures of a Streptomyces sp. inhibits cathepsin K New Synthesized Tri-Peptide as Inhibitor of Krait (Bungarus Sindanus) Venom Acetylcholinesterase Triazole pyrimidine nucleosides as inhibitors of Ribonuclease A. Synthesis, biochemical, and structural evaluation Ribose-Modified Purine Nucleosides as Ribonucleotide Reductase Inhibitors. Synthesis, Antitumor Activity, and Molecular Modeling of N⁶-Substituted 3′-C-Methyladenosine Derivatives Inhibitors of Tripeptidyl Peptidase II. 2. Generation of the First Novel Lead Inhibitor of Cholecystokinin-8-Inactivating Peptidase:  A Strategy for the Design of Peptidase Inhibitors P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors On-Bead Screening of a Combinatorial Fumaric Acid Derived Peptide Library Yields Antiplasmodial Cysteine Protease Inhibitors with Unusual Peptide Sequences